Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Non-Current Deferred Tax Liability (2021 - 2025)

Medicinova (MNOV) has disclosed Non-Current Deferred Tax Liability for 7 consecutive years, with $201792.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A to $201792.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $201792.0, a N/A change, with the full-year FY2025 number at $201792.0, changed N/A from a year prior.
  • Non-Current Deferred Tax Liability was $201792.0 for Q4 2025 at Medicinova, roughly flat from $201792.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $201792.0 in Q1 2021 to a low of $201792.0 in Q1 2021.
  • A 5-year average of $201792.0 and a median of $201792.0 in 2021 define the central range for Non-Current Deferred Tax Liability.
  • Biggest YoY gain for Non-Current Deferred Tax Liability was 0.0% in 2022; the steepest drop was 0.0% in 2022.
  • Medicinova's Non-Current Deferred Tax Liability stood at $201792.0 in 2021, then changed by 0.0% to $201792.0 in 2022, then changed by 0.0% to $201792.0 in 2023, then changed by 0.0% to $201792.0 in 2024, then changed by 0.0% to $201792.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Non-Current Deferred Tax Liability are $201792.0 (Q4 2025), $201792.0 (Q3 2025), and $201792.0 (Q2 2025).